Platycodin D-induced apoptosis through nuclear factor-κB activation in immortalized keratinocytes

European Journal of Pharmacology

Volumn 537, Issue 1-3, 2006, Pages 1-11

  Ahn, Kwang Seok ^a,d   Hahn, Bum Soo ^b   Kwack, KyuBum ^c   Lee, Eun Bang ^a   Kim, Yeong Shik ^a  

^a Seoul National University   (South Korea)

^b National Institute of Animal Science   (South Korea)

^c CHA University   (South Korea)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Apoptosis; Caspase 3 and 8; Fas and Fas ligand; HaCaT cells; NF B activation; Platycodin D

Indexed keywords

CASPASE 3; CASPASE 8; DEATH RECEPTOR; DNA FRAGMENT; FAS ANTIGEN; FAS LIGAND; I KAPPA B; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PLATYCODIN; PROTEIN P53; SAPONIN DERIVATIVE; TOSYLPHENYLALANYL CHLOROMETHYL KETONE; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; BINDING SITE; CELL IMMORTALIZATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INCUBATION TIME; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RECEPTOR UPREGULATION;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; CASPASE 3; CASPASE 8; CASPASES; CELL LINE; CELL LINE, TUMOR; CELL SURVIVAL; DNA FRAGMENTATION; FAS LIGAND PROTEIN; GENE EXPRESSION REGULATION; HUMANS; I-KAPPA B KINASE; IN SITU NICK-END LABELING; KERATINOCYTES; MEMBRANE GLYCOPROTEINS; MICE; NF-KAPPA B; RNA, MESSENGER; SAPONINS; TRITERPENES; TUMOR NECROSIS FACTORS;

EID: 33646153996     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.03.012     Document Type: Article

References (41)

1. Ahn K.S., Moon K.Y., Lee J., and Kim Y.S. Downregulation of NF-κB melanogenic inhibitors. J. Dermatol. Sci. 31 (2003) 193-201
2. Ahn K.S., Noh E.J., Zhao H.L., Jung S.H., Kang S.S., and Kim Y.S. Inhibition of inducible nitric oxide synthase and cyclooxygenase II by Platycodon grandiflorum saponins via suppression of nuclear factor-κB activation in RAW 264.7 cells. Life Sci. 76 (2005) 2315-2328
3. Ashkenazi A., and Dixit V.M. Death receptors: signaling and modulation. Science 281 (1998) 1305-1308
4. Baeuerle P.A. The inducible transcription activator NF-κB: regulation by distinct protein subunits. Biochim. Biophys. Acta 1072 (1991) 63-80
5. Baeuerle P.A., and Baichwal V.R. NF-κB as a frequent target for immunosuppressive and anti-inflammatory molecules. Adv. Immunol. 65 (1997) 111-137
6. Boukamp P., Petrussevska R.T., Breitkreutz D., Hornung J., Markham A., and Fusenig N.E. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol. 106 (1988) 761-771
7. Bush J.A., Cheung Jr. K.J., and Li G. Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53. Exp. Cell Res. 271 (2001) 305-314
8. Chen F., Castranova V., and Shi X. New insights into the role of nuclear factor-κB in cell growth regulation. Am. J. Pathol. 159 (2001) 387-397
9. Choi C.Y., Kim J.Y., Kim Y.S., Chung Y.C., Hahm K.S., and Jeong H.G. Augmentation of macrophage functions by an aqueous extract isolated from Platycodon grandiflorum. Cancer Lett. 166 (2001) 17-25
10. Dunn C., Wiltshire C., MacLaren A., and Gillespie D.A. Molecular mechanism and biological functions of c-Jun N-terminal kinase signalling via the c-Jun transcription factor. Cell. Signal. 14 (2002) 585-593
11. Earnshaw W.C., Martins L.M., and Kaufmann S.H. Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu. Rev. Biochem. 68 (1999) 383-424
12. Fujita M., Goto K., Yoshida K., Okamura H., Morimoto H., Kito S., Fukuda J., and Haneji T. Okadaic acid stimulates expression of Fas receptor and Fas ligand by activation of NF-κB in human oral squamous carcinoma cells. Oral Oncol. 40 (2004) 199-206
13. Goto K., Fukuda J., and Haneji T. Okadaic acid stimulates apoptosis through expression of Fas receptor and Fas ligand in human oral squamous carcinoma cells. Oral Oncol. 38 (2002) 16-22
14. Green D.R., and Reed J.C. Mitochondria and apoptosis. Science 281 (1998) 1309-1312
15. Hill L.L., Ouhtit A., Loughlin S.M., Kripke M.L., Ananthaswamy H.N., and Owen-Schaub L.B. Fas ligand: a sensor for DNA damage critical in skin cancer etiology. Science 285 (1999) 898-900
16. Ishiyama M., Tominaga H., Shiga M., Sasamoto K., Ohkura Y., and Ueno K. A combined assay of cell viability and in vitro cytotoxicity with a highly water-soluble tetrazolium salt, neutral red and crystal violet. Biol. Pharm. Bull. 19 (1996) 1518-1520
17. Israels L.G., and Israels E.D. Apoptosis. Stem Cells 17 (1999) 306-313
18. Kasibhatla S., Brunner T., Genestier L., Echeverri F., Mahboubi A., and Green D.R. DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-κB and AP-1. Mol. Cell 1 (1998) 543-551
19. Kasibhatla S., Genestier L., and Green D.R. Regulation of fas-ligand expression during activation-induced cell death in T lymphocytes via nuclear factor kappaB. J. Biol. Chem. 274 (1999) 987-992
20. Kerr J.F., Wyllie A.H., and Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26 (1972) 239-257
21. Kim Y.P., Lee E.B., Kim S.Y., Li D., Ban H.S., Lim S.S., Shin K.H., and Ohuchi K. Inhibition of prostaglandin E2 production by platycodin D isolated from the root of Platycodon grandiflorum. Planta Med. 67 (2001) 362-364
22. Lee E.B. Pharmacological studies on Platycodon grandiflorum A. DC. IV. A comparison of experimental pharmacological effects of crude platycodin with clinical indications of Platycodi Radix (author's transl). Yakugaku Zasshi vol. 93 (1973) 1188-1194
23. Mammone T., Gan D., Collins D., Lockshin R.A., Marenus K., and Maes D. Successful separation of apoptosis and necrosis pathways in HaCaT keratinocyte cells induced by UVB irradiation. Cell Biol. Toxicol. 16 (2000) 293-302
24. Matsui K., Fine A., Zhu B., Marshak-Rothstein A., and Ju S.T. Identification of two NF-κB sites in mouse CD95 ligand (Fas ligand) promoter: functional analysis in T cell hybridoma. J. Immunol. 161 (1998) 3469-3473
25. Moon K.Y., Ahn K.S., Lee J., and Kim Y.S. Kojic acid, a potential inhibitor of NF-κB activation in transfectant human HaCaT and SCC-13 cells. Arch. Pharm. Res. 24 (2001) 307-311
26. Moon K.Y., Hahn B.S., Lee J., and Kim Y.S. A cell-based assay system for monitoring NF-κB activity in human HaCaT transfectant cells. Anal. Biochem. 292 (2001) 17-21
27. Nicholson D.W., Ali A., Thornberry N.A., Vaillancourt J.P., Ding C.K., Gallant M., Gareau Y., Griffin P.R., Labelle M., and Lazebnik Y.A. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376 (1995) 37-43
28. Ozaki Y. Studies on antiinflammatory effect of Japanese Oriental medicines (kampo medicines) used to treat inflammatory diseases. Biol. Pharm. Bull. 18 (1995) 559-562
29. Schuler M., and Green D.R. Mechanisms of p53-dependent apoptosis. Biochem. Soc. Trans. 29 (2001) 684-688
30. Scudiero D.A., Shoemaker R.H., Paull K.D., Monks A., Tierney S., Nofziger T.H., Currens M.J., Seniff D., and Boyd M.R. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res. 48 (1988) 4827-4833
31. 3 increase airway mucin release in vivo and in vitro in rats and hamsters. Planta Med. 68 (2002) 221-225
32. Somasundaram K. Tumor suppressor p53: regulation and function. Front. Biosci. 5 (2000) D424-D437
33. Tada A., Kaneiwa Y., Shoji J., and Shibata S. Studies on the saponins of the root of Platycodon grandiflorum A. De Candolle. I. Isolation and the structure of platycodin-D. Chem. Pharm. Bull. (Tokyo) 23 (1975) 2965-2972
34. Takagi K., and Lee E.B. Pharmacological studies on Platycodon grandiflorum A. DC. 3. Activities of crude platycodin on respiratory and circulatory systems and its other pharmacological activities. Yakugaku Zasshi vol. 92 (1972) 969-973
35. Thornberry N.A., and Lazebnik Y. Caspases: enemies within. Science 281 (1998) 1312-1316
36. Viard I., Wehrli P., Bullani R., Schneider P., Holler N., Salomon D., Hunziker T., Saurat J.H., Tschopp J., and French L.E. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 282 (1998) 490-493
37. Wahl C., Liptay S., Adler G., and Schmid R.M. Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B. J. Clin. Invest. 101 (1998) 1163-1174
38. Wajant H. The Fas signaling pathway: more than a paradigm. Science 296 (2002) 1635-1636
39. Weber C.K., Liptay S., Wirth T., Adler G., and Schmid R.M. Suppression of NF-κB activity by sulfasalazine is mediated by direct inhibition of IkappaB kinases alpha and beta. Gastroenterology 119 (2000) 1209-1218
40. Wulczyn F.G., Krappmann D., and Scheidereit C. The NF-κB Rel and I-κB gene families: mediators of immune response and inflammation. J. Mol. Med. 74 (1996) 749-769
41. Zhao H.L., Sim J.S., Shim S.H., Ha Y.W., Kang S.S., and Kim Y.S. Antiobese and hypolipidemic effects of platycodin saponins in diet-induced obese rats: evidences for lipase inhibition and calorie intake restriction. Int. J. Obes. (Lond) 29 (2005) 983-990